文献速递免疫规划卫生政策与健康促进

SIVAC倡议支持对中低收入国家NITAG功能性的影响评估

Strengthening national vaccine decision-making: Assessing the impact of SIVAC Initiative support on national immunisation technical advisory group (NITAG) functionality in 77 low and middle-income countries.
PubMed 文献 · Vaccine · 2018-12-10

该研究利用WHO/Unicef联合报告表数据,对77个中低收入国家进行Cox比例风险模型分析,评估SIVAC倡议支持与国家免疫技术咨询组(NITAG)功能性之间的关系。结果显示,接受SIVAC支持的国家报告功能性的平均时间为2.00年(95%CI 1.40-2.60),未接受支持的国家为2.82年(95%CI 2.05-3.59),提示SIVAC支持可能加快NITAG实现功能性。

要点

  • 该关联不能完全由人均GDP、卫生支出占比或初始NITAG功能性评分解释。
  • JRF数据质量较差,尤其未受支持国家,可能影响结果解读。

核心结论

  • SIVAC支持可能帮助许多国家更快速地实现NITAG功能性。

研究设计与样本

  • 基于WHO/Unicef联合报告表(JRF)数据,对77个中低收入国家进行回顾性队列分析,采用Cox比例风险模型评估SIVAC支持与NITAG功能性时间的关系。

主要发现

  • 接受SIVAC支持的国家报告NITAG功能性的平均时间为2.00年(95%CI 1.40-2.60),未接受支持的国家为2.82年(95%CI 2.05-3.59)。
  • SIVAC支持与缩短NITAG实现功能性的时间相关,且该关联不能完全由人均GDP、卫生支出占GDP百分比或研究开始时NITAG功能性评分解释。

临床怎么用

  • 在资源有限地区,可考虑通过类似SIVAC的针对性支持来加速NITAG的建立与功能完善。

局限性

  • 用于计算NITAG功能性的JRF数据质量较差,尤其在接受SIVAC支持较少的国家。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: National Immunisation Technical Advisory Groups (NITAGs) are multi-disciplinary expert groups that provide policy-makers with independent, evidence-based advice on vaccination. Between 2008 and 2017, the SIVAC Initiative supported establishment and strengthening of NITAGs in low and lower-middle income countries though its impact was never assessed quantitatively. AIM: To quantitatively assess whether SIVAC support is associated with a faster rate at which NITAGs became functional based on six performance indicators. METHODS: Data from the World Health Organization/Unicef Joint Reporting Form (JRF) from 77 low and lower-middle-income countries were used to examine the time delay between the start of SIVAC support and NITAG functionality using a Cox proportional hazards model. RESULTS: Countries receiving SIVAC support took a mean of 2.00 (95% CI 1.40-2.60) years to reported functionality compared to 2.82 (95% CI 2.05-3.59) years for countries without SIVAC support. We found evidence that SIVAC support is associated with reduced time until NITAG functionality, and this association cannot fully be explained by GDP per capita, percentage of GDP spent on healthcare, or NITAG functionality score at the start of the study period. However, quality of JRF data for the questions used to calculate NITAG functionality were poor, particularly for countries not receiving SIVAC support. CONCLUSION: SIVAC support is likely to have enabled many countries to more rapidly achieve NITAG functionality.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. van Zandvoort K, Howard N, Mounier-Jack S, et al. Strengthening national vaccine decision-making: Assessing the impact of SIVAC Initiative support on national immunisation technical advisory group (NITAG) functionality in 77 low and middle-income countries. Vaccine. 2018. PMID: 30545715. doi:10.1016/j.vaccine.2018.11.070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。